$CBIS Retains i-Business Management, LLC for Investor and Public Relations

“When you have a company with as many products and target markets as Cannabis Science, it is vital to send a consistent key message across brands while providing appropriate, product-specific variation,” stated Joshua Slate, a technical writer for i-Business Management. “To give a high level overview, we develop an understanding of the parent corporation’s vision and values and find ways to integrate them into each individual product’s branding campaign.”

Teresa Misenheimer, acting President of i-Business Management, LLC, stated, “As Cannabis Science continues to expand their products into varying industries, it has become increasingly important to ensure the company’s values are properly expressed through each brand, but also that the message is appropriately fitted for the unique target markets of each product group.”

She continued, “It is time to enhance the CBIS social media portfolio; we need to transform it from what it is now–a limited and underutilized resource–into a more vibrant and complete presence. From traditional forums to non-traditional networking within the social media matrix, our goal is to attain reach to a global audience.”

“Our decision to retain i-Business Management as an external investor and public relations provider stems from the authenticity, depth, and impact of their work. They pride themselves on quality work product geared towards corporate/brand image and reputation. They have an impressive list of satisfied clients, and we’re looking forward to seeing what the company can do for us in streamlining product introductions, communications with investors and customers moving forward,” stated Cannabis Science Inc., President & CEO, Co-Founder, Raymond C. Dabney.

Regarding general public relations strategy, Ms. Misenheimer stated, “We look to have an active corporate blog in addition to the standard social media profiles found optimal for corporate use. We intend to streamline communications and deepen existing channels while also forging new ones to reach new investors.”

Mr. Dabney concluded, “Things have really progressed, we are very busy and very pleased with our progress to this point. Change is no longer an option, but a requirement. The California product expansion is well underway and new products are coming out in a number of new areas. Adding to that, the multiple national and international drug development programs, and working on the completion of dividends, as well as other financial reports …. seemingly a recipe for a serious hectic growth experience!

“As there is never enough time for me speak to every shareholder the way I would like to, I believe nowthe best way for me to make sure my message is clear to the number of people I now need to reach is through a strong social and national media agenda that is coupled with a competent, committed, and focused Investor Relations team. I believe we have found that with i-Business; they are waiting for your call.”

About i-Business Management, LLC:
i-Business Management, LLC is an investor relations and public relations firm specializing in corporate branding, enhancing shareholder value, and helping clients develop their businesses. The company believes in forming long-term, mutually beneficial relationships that add value to their clients’ businesses. This means operating with integrity, accuracy, and general diligence, and they demand the same from their clients, which are thoroughly screened. Offering the customer service, attention to detail, and flexibility of a boutique firm, but the resources of a full agency. The company’s carefully assembled team of professionals produces immediate impact and sustainable results for their clients.

About Cannabis Science, Inc.
Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

Forward-Looking Statements This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc., does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company are detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.